Pfizer-Biontech COVID vaccine to be mass produced, distributed after WHO certification

Ogunsakin Mustapha
1 Min Read

By Abubakar Hashim

US pharmaceutical giant, Pfizer, in partnership with German Biontech, having successfully produced COVID Vaccine, will commence mass production after the World Health Organization(WHO) soon.

- Advertisement -
Ad image

Pfizer claimed that the vaccine is 90% effective, and tested on 43,547 humans in 6 countries. It is targeted for equal distribution after WHO certification.

This development is coming on the heels of similar vaccine by a British-Swedish drug giant, Astra Venica, but produced side effects on humans last September.

- Advertisement -
Ad image

This latest Pfizer-Biontech COVID Vaccine is a groundbreaking development in view of its efficacy and safety on humans in recent clinical trials.

African countries are expecting fair distribution through funding by private sector players, like AFREXIM Bank, 5 Billion Dollars in concessional loans, AfDB , 5.6 Billion Dollars and other multinational conglomerates, to support African countries to benefit from the vaccines.

- Advertisement -
Ad image

Dear readers, we really need your support to keep on serving you with authoritative, truthful, and juicy stories everyday. For your support, please reach out to the editor @gavelinternational66@gmail.com

- Advertisement -
Ad image

Share This Article
error: Content is protected !!